Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
3.40    0.00 (0.00%)
Bid:
3.30
Ask:
3.50
Spread: 0.20 (6.061%)
Market Cap: £5.09m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Director/PDMR Share Dealing

11 Mar 2025 16:56

RNS Number : 2525A
Ondo InsurTech PLC
11 March 2025
 

11 March 2025

Ondo Insurtech Plc

("Ondo" or the "Company")

 

Director/PDMR Share dealing

 

Ondo Insurtech (LSE: ONDO), a leading company in claims prevention technology for home insurers, announces that Charlene Hill, spouse of Chief Executive, Craig Foster, exercised warrants over 125,000 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares") at an exercise price of 25 pence per warrant on 7 March 2025 ("New Ordinary Shares"). On the same day, Charlene Hill also sold 105,000 Ordinary shares (to cover taxes and exercise costs) at a price of 35.8 pence, having previously held 250,000 Ordinary Shares. Following the warrant exercise and share sale Charlene Hill is now interested in 270,000 Ordinary Shares, which represents approximately 0.21% of the issued share capital of the Company.

 

The New Ordinary Shares have been admitted to listing on the Equity Shares (Transition) category of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities under the Company's block listing.

 

Charlene Hill's interests in the Company were acquired through her participation in the fundraising undertaken by the Company in March 2022 in conjunction with its acquisition of the entire issued share capital of LeakBot Limited by way of a reverse takeover. At that time Charlene Hill was not a person closely associated ("PCA") with Craig Foster for UK MAR purposes. Following their marriage in August 2023, Charlene Hill has been a PCA with Craig Foster and accordingly, her interests should have been incorporated with and reflected when reporting the interests of Craig Foster, but this disclosure was not made in error.

 

Craig Foster's interests in the Company as at 1 August 2023 were as set out below:

 

 

Shareholding at August 2023

% of issued share capital

Number of warrants

Number of share options

Craig Foster

1,779,567

2.23%

889,783

2,320,000

Charlene Hill

250,000

0.32%

125,000

-

Total

2,029,567

2.55%

1,014,783

2,320,000

 

Following the share sale and exercise of warrants described above, as at 11 March 2025, Craig Foster's beneficial interests in the Company are now:

 

 

Shareholding(1)

% of issued share capital

Number of warrants

Number of share options

Craig Foster

2,448,844

1.90%

-

3,920,000

 

(1) 270,000 Ordinary Shares are held by Craig Foster's wife

 

 

 

Enquiries

 

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Nick Chambers

Charlie Hall

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

 +44 (0) 7949 690338

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

 

1.

Details of PDMR / person closely associated with them ("PCA").

a)

Name

Charlene Hill

2

Reason for notification

a)

Position/Status

PCA - spouse of Craig Foster, Chief Executive and PDMR

b)

Initial Notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

Ordinary shares of 5 pence each

instrument, type of instrument

 

Identification code

ISIN: GB00BNVVGD77

b)

Nature of transaction

Exercise of warrants for ordinary shares

c)

Price(s) and volume(s)

Exercise of warrants over 125,000 Ordinary Shares at an exercise price of 25 pence per warrant

 

d)

Aggregated information

n/a

e)

Date of transaction

7 March 2025

f)

Place of transaction

Outside of a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA").

a)

Name

Charlene Hill

2

Reason for notification

a)

Position/Status

PCA - spouse of Craig Foster, Chief Executive and PDMR

b)

Initial Notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

Ordinary shares of 5 pence each

instrument, type of instrument

 

Identification code

ISIN: GB00BNVVGD77

b)

Nature of transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

 

Price

Volumes

35.8p

105,000

 

 

d)

Aggregated information

n/a

e)

Date of transaction

7 March 2025

f)

Place of transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQFLFFEXLEBBX
Date   Source Headline
2nd Jun 20265:56 pmRNSShare Incentive Plan Purchase
28th May 20267:00 amRNSVendor Loan Note Restructuring
21st May 20267:00 amRNSAppointment of Non-Executive Director
6th May 20267:00 amRNSShare Incentive Plan Purchase
23rd Apr 202611:01 amRNSChange of Board Responsibilities
21st Apr 20263:30 pmRNSTrading Update for the Year Ended 31 March 2026
13th Apr 20267:00 amRNS-RAlm. Brand Group Extends LeakBot Programme
13th Apr 20267:00 amRNSBoard Changes
8th Apr 202610:59 amRNSShare Incentive Plan Purchase
4th Mar 20265:19 pmRNSShare Incentive Plan Purchase
4th Mar 20267:00 amRNSOndo Extends Contract with Selective Insurance
12th Feb 20267:00 amRNSU.S. Contract Win
9th Feb 20267:00 amRNSAlm. Brand Group to roll out LeakBot
30th Jan 20264:50 pmRNSBlock Listing Update - Warrant Plan
30th Jan 20262:01 pmRNSBlock Listing Update - Option Plan
30th Jan 20262:00 pmRNSDirector/PDMR Shareholding
14th Jan 20267:00 amRNSAppointment of Joint Corporate Broker
2nd Jan 20264:45 pmRNSDirector/PDMR Shareholding
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
17th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20259:50 amRNSHolding(s) in Company
9th Dec 20257:00 amRNSIssue of Equity - Result of WRAP Retail Offer
5th Dec 20253:21 pmRNSUpdate to Placing and Admission
4th Dec 20257:50 amRNSLaunch of WRAP Retail Offer
4th Dec 20257:00 amRNSResult of ABB
3rd Dec 20257:00 amRNSPlacing and Subscription via ABB
3rd Dec 20257:00 amRNSHalf-year Financial Report
1st Dec 20257:00 amRNSChange of Registered Office
27th Nov 20253:33 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSNotice of Results
24th Nov 20257:00 amRNSContract
19th Nov 20257:00 amRNSContract Win
10th Nov 20257:00 amRNSContract Win
3rd Nov 20255:01 pmRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTotal Voting Rights
9th Oct 202510:46 amRNSDirector/PDMR Shareholding
30th Sep 20254:58 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSTotal Voting Rights
22nd Sep 20254:08 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
4th Sep 20253:30 pmRNSDirector/PDMR Shareholding
3rd Sep 20257:00 amRNSContract
26th Aug 20257:00 amRNS-RTopdanmark agreement update
15th Aug 20253:00 pmRNSNotice of AGM
4th Aug 20254:47 pmRNSHolding(s) in Company
4th Aug 20253:10 pmRNSHolding(s) in Company
4th Aug 20257:00 amRNSDirectorate Change
1st Aug 20251:32 pmRNSDirector/PDMR Shareholding
1st Aug 20259:03 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.